The novel η 2 -N 2 -diazoalkane complex Cp* 2 Ti(N 2 CHSiMe 3 ) (2) has been prepared by addition of (trimethylsilyl)diazomethane to Cp* 2 Ti(C 2 H 4 ) (1). The structure of 2 reveals nearly symmetric Ti-N distances and an N-N distance ∼0.1 Å longer than that of the free diazoalkane. Compound 2 loses dinitrogen in solution under mild conditions to give the fulvene complex Cp*FvTiCH 2 SiMe 3 (4). Thermolysis of 2 in the presence of 1-alkenes yields the trans-R, -disubstituted titanacyclobutane complexes Cp* 2 Ti(CH(SiMe 3 )CH- (9)). The regio-and stereochemistry of the titanacyclobutane complexes was determined by a combination of one-and two-dimensional NMR techniques. The NMR assignment was supported in the case of 8 by an X-ray diffraction study. In addition to confirming the regio-and stereochemistry of the metallacycle, the X-ray structure of 8 shows that unlike most titanacyclobutanes, the metallacycle ring is puckered. A kinetic study of the formation of 7 from 2 and styrene revealed that the reaction is first order in 2 and zero order in styrene. The rate constant for this reaction is identical to that measured for the conversion of 2 to 4. The kinetic study supports a mechanism involving initial rate-determining loss of dinitrogen to form a carbene complex intermediate which undergoes hydrogen transfer from a Cp* methyl to give 4, or in the presence of styrene is trapped to form 7. In addition to its metal carbene-like reactions involving N 2 loss, complex 2 undergoes a variety of transformations in which N 2 is retained in the final product. These include cycloaddition reactions with alkynes and allene, as well as reversible reactions with Lewis bases to form adducts. These transformations, which are similar to reactions of group IV imido complexes, demonstrate the imide-like character of the diazoalkane ligand.
A series of η2-N2-titanium aryldiazoalkane complexes Cp*2Ti(N2CHAr) (5−10), where Ar is a para-substituted aryl group, have been prepared by addition of aryldiazoalkanes to Cp*2Ti(C2H4) (4). Unlike most
diazoalkane complexes, they release dinitrogen thermally to give transient carbene complexes which may be
trapped with styrene to form the titanacyclobutane complexes Cp*2Ti(CHArCHPhCH2) (11−15). The kinetics
of these reactions in toluene-d
8 at 78.0 °C have been examined by 1H NMR spectroscopy. A Hammett analysis
(ρ = − 0.26) indicated that the reaction is relatively insensitive to para-substituents on the aromatic ring of
the diazoalkane ligand, but application of the E- and C-based dual parameter substituent constant analysis
suggests that this may be due to almost exactly compensating covalent and electrostatic contributions of each
substituent to the reaction rate. The stability of the aryldiazoalkane complexes at temperatures below 75 °C
allows their reactivity to be explored without competitive N2 loss. The addition of tBuNC results in a
coordination change of the diazoalkane fragment from η2 to η1 to give Cp*2Ti(η1-N2CHPh)(tBuNC) (16), as
shown by 15N NMR chemical shifts and N−H coupling constants. The bound tBuNC ligand exchanges with
free tBuNC in solution, as established by an EXSY experiment. Trineopentylaluminum coordinates to the
terminal nitrogen atom on the diazoalkane fragment to form Cp*2TiN(AlNp3)N(C(H)C6H4Me) (17), as
determined by X-ray crystallography. Silanes (HSiR3; R3 = PhH2, Ph2H) add across the Ti−N bond of Cp*2Ti(N2C(H)C6H4Me) to give (E)-Cp*2Ti(H)(N(SiR3)(NC(H)C6H4Me) ((E)-19, (E)-20), the kinetic product
and (Z)-Cp*2Ti(H)(N(SiR3)(NC(H)C6H4Me) ((Z)-19, (Z)-20), the thermodynamic product. Diazoalkane adduct
Cp*2Ti(N2C(H)C6H4Me) undergoes N−N bond cleavage when treated with CO to form an alkylideneimido
isocyanato complex Cp*2Ti(NCO)NC(H)C6H4Me) (21).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.